Category Archives: Healthcare

Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (NASDAQ: CRSP) and Alector (NASDAQ: ALEC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Crispr Therapeutics AG (CRSP – Research Report) and Alector (ALEC – Research Report) with bullish sentiments. Crispr Therapeutics AG (CRSP) Barclays analyst

Assembly Biosciences (ASMB) Receives a Buy from Robert W. Baird

In a report issued on February 26, Brian Skorney from Robert W. Baird maintained a Buy rating on Assembly Biosciences (ASMB – Research Report). The company’s shares closed last Friday at $5.08, close to its 52-week low of $4.78. According

Jounce Therapeutics (JNCE) Gets a Buy Rating from Robert W. Baird

Robert W. Baird analyst Michael Ulz reiterated a Buy rating on Jounce Therapeutics (JNCE – Research Report) on February 25. The company’s shares closed last Friday at $10.98. According to TipRanks.com, Ulz is a 4-star analyst with an average return

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (NASDAQ: IRTC), Odonate Therapeutics (NASDAQ: ODT) and Atreca (NASDAQ: BCEL)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Irhythm Technologies (IRTC – Research Report), Odonate Therapeutics (ODT – Research Report) and Atreca (BCEL – Research Report). Irhythm Technologies (IRTC) Robert W.

J.P. Morgan Downgrades Editas Medicine (EDIT) to Sell

Editas Medicine (EDIT – Research Report) received a Sell rating and a $30.00 price target from J.P. Morgan analyst Cory Kasimov today. The company’s shares closed last Friday at $43.86. According to TipRanks.com, Kasimov is a 5-star analyst with an

Brookline Capital Markets Initiates a Buy Rating on Kura Oncology (KURA)

Brookline Capital Markets analyst Leah R. Cann initiated coverage with a Buy rating on Kura Oncology (KURA – Research Report) on February 24 and set a price target of $40.00. The company’s shares closed last Friday at $28.00. According to